Sukocheva and coworkers showed in MCF-7 breast cancer cells that estradiol increased SphK1 activity and the formation of S1P, with subsequent binding of S1P to one of its receptors, S1P3, which in turn transactivated EGFR [49, 50]. Here, EGFR is linked to breast cancer.